Experts question value of SPECT for diabetics

09/1/2009 | HealthImaging.com

A sub-analysis using SPECT myocardial perfusion scintigraphy on patients with Type 2 diabetes and mild angina found that the severity of myocardial perfusion defects can be linked to cardiac death and nonfatal myocardial ischemia. The study showed "the accuracy of SPECT imaging for risk stratification in a prospectively identified patient population," but failed "to justify the widespread use of SPECT for risk stratification purposes in asymptomatic or mildly symptomatic diabetic patients," two experts said in an editorial regarding the study.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI